AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (AGIO)

Q: What does CUSIP 00847X104 represent in this 13F holders report?

CUSIP 00847X104 is the security identifier for AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in Q4 2016?

154 institutional investors reported AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share for Q4 2016. Use the holders table for investor-level position and value details.

CUSIP: 00847X104

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 59,097,039
Total 13F shares: 39,019,883
Share change: +1,218,978
Total reported value: $1,628,427,134
Put/Call ratio: 30%
Price per share: $41.73
Number of holders: 154
Value change: +$42,873,951
Number of buys: 79
Number of sells: 73

Quarterly Holders Quick Answers

What is CUSIP 00847X104?
CUSIP 00847X104 identifies AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2017
Previous quarter: Q3 2016

Recent filing periods for CUSIP 00847X104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	11%	6,211,072	$328,069,000	—	30 Sep 2016	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	9.8%	5,798,331	$306,268,000	—	30 Sep 2016	13F
BB BIOTECH AG	13F	Company	4.5%	2,649,528	$139,948,000	—	30 Sep 2016	13F
VANGUARD GROUP INC	13F	Company	4%	2,364,221	$124,879,000	—	30 Sep 2016	13F
Capital International Investors	13F	Company	2.5%	1,504,896	$79,489,000	—	30 Sep 2016	13F
Clearbridge Investments, LLC	13F	Company	2.5%	1,458,751	$77,051,000	—	30 Sep 2016	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.1%	1,239,924	$65,493,000	—	30 Sep 2016	13F
STATE STREET CORP	13F	Company	1.8%	1,090,341	$57,594,000	—	30 Sep 2016	13F
Flagship Pioneering, LLC	13F	Company	1.6%	965,369	$50,991,000	—	30 Sep 2016	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	1.6%	920,704	$48,632,000	—	30 Sep 2016	13F
BlackRock Fund Advisors	13F	Company	1.4%	810,238	$42,797,000	—	30 Sep 2016	13F
Redmile Group, LLC	13F	Company	1.2%	737,900	$38,976,000	—	30 Sep 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.2%	698,214	$36,880,000	—	30 Sep 2016	13F
Capital World Investors	13F	Company	1.1%	663,000	$35,020,000	—	30 Sep 2016	13F
FIRST TRUST ADVISORS LP	13F	Company	1.1%	650,332	$34,351,000	—	30 Sep 2016	13F
CAPITAL GUARDIAN TRUST CO	13F	Company	1.1%	640,200	$33,815,000	—	30 Sep 2016	13F
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F	Company	1.1%	625,627	$33,046,000	—	30 Sep 2016	13F
LORD, ABBETT & CO. LLC	13F	Company	0.86%	508,469	$26,857,000	—	30 Sep 2016	13F
Artal Group S.A.	13F	Company	0.68%	400,000	$21,128,000	—	30 Sep 2016	13F
BLACKROCK ADVISORS LLC	13F	Company	0.65%	385,747	$20,375,000	—	30 Sep 2016	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	0.57%	338,755	$17,893,000	—	30 Sep 2016	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.51%	302,889	$15,999,000	—	30 Sep 2016	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.51%	300,800	$15,888,000	—	30 Sep 2016	13F
CITADEL ADVISORS LLC	13F	Company	0.48%	282,719	$14,933,000	—	30 Sep 2016	13F
Casdin Capital, LLC	13F	Company	0.48%	282,443	$14,919,000	—	30 Sep 2016	13F
CAPITAL INTERNATIONAL LTD /CA/	13F	Company	0.44%	262,800	$13,881,000	—	30 Sep 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.37%	219,502	$11,593,000	—	30 Sep 2016	13F
NORGES BANK	13F	Company	0.38%	221,697	$11,184,000	—	30 Sep 2016	13F
BAKER BROS. ADVISORS LP	13F	Company	0.35%	207,915	$10,982,000	—	30 Sep 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.34%	203,180	$10,728,000	—	30 Sep 2016	13F
EcoR1 Capital, LLC	13F	Company	0.34%	200,000	$10,564,000	—	30 Sep 2016	13F
BlackRock Group LTD	13F	Company	0.34%	199,561	$10,540,000	—	30 Sep 2016	13F
JENNISON ASSOCIATES LLC	13F	Company	0.29%	169,252	$8,940,000	—	30 Sep 2016	13F
BARCLAYS PLC	13F	Company	0.27%	160,838	$8,495,000	—	30 Sep 2016	13F
NORTHERN TRUST CORP	13F	Company	0.26%	151,467	$8,000,000	—	30 Sep 2016	13F
Avoro Capital Advisors LLC	13F	Company	0.25%	150,000	$7,923,000	—	30 Sep 2016	13F
Capital International Sarl	13F	Company	0.25%	147,400	$7,786,000	—	30 Sep 2016	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.23%	133,306	$7,041,000	—	30 Sep 2016	13F
Opaleye Management Inc.	13F	Company	0.22%	130,000	$6,867,000	—	30 Sep 2016	13F
CREDIT SUISSE AG/	13F	Company	0.21%	122,349	$6,462,000	—	30 Sep 2016	13F
Clarius Group, LLC	13F	Company	0.18%	109,230	$5,770,000	—	30 Sep 2016	13F
MARSHALL WACE, LLP	13F	Company	0.18%	107,423	$5,675,000	—	30 Sep 2016	13F
Bank of New York Mellon Corp	13F	Company	0.18%	106,823	$5,641,000	—	30 Sep 2016	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.17%	101,707	$5,372,000	—	30 Sep 2016	13F
MORGAN STANLEY	13F	Company	0.17%	98,079	$5,181,000	—	30 Sep 2016	13F
CAPITAL FUND MANAGEMENT S.A.	13F	Company	0.16%	95,510	$5,045,000	—	30 Sep 2016	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.15%	87,240	$4,608,000	—	30 Sep 2016	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.14%	85,405	$4,511,000	—	30 Sep 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	84,412	$4,459,000	—	30 Sep 2016	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.13%	79,656	$4,208,000	—	30 Sep 2016	13F

Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (AGIO) as of Q4 2016

As of 31 Dec 2016, AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (AGIO) was held by 154 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,019,883 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BB BIOTECH AG, Capital International Investors, VANGUARD GROUP INC, Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Flagship Pioneering Inc., and BlackRock Fund Advisors. This page lists 154 institutional shareholders reporting positions in this security for the Q4 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders

160

Q4 2016 holders

154

Holder diff

-6

Investor	Q3 2016 Shares	Q4 2016 Shares	Share Diff	Share Chg %	Q3 2016 Value $	Q4 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.